Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardioprotective Effect of Dexmedetomidine in Cardiac Surgery
NCT04871308Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in Myocardial injury and ischemia-reperfusion injury (IRI) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Cardiac Troponin I at 3 days. Started Jul 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Myocardial injuryischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT04871308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04871308.